health

Bristol-Myers wins approval for 1st hepatitis C type 3 drug

2 Comments
By LINDA A. JOHNSON

The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.

© Copyright 2015 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

©2024 GPlusMedia Inc.

2 Comments
Login to comment

Bristol-Myers said the list price for Daklinza, also known as daclatascir, will be $63,000 for a 12-week course of treatment.

Job well done by FDA, but the medications will not be available to patients for cure in reality. We need to do something about these pharmaceutical companies and health insurance companies in US. They are just criminals in humanity!

0 ( +0 / -0 )

Hepatitis C can now be 100% cured within 12 weeks by nano-medication regardless of the genotype. Cost: US$10,000. Cirrhosis can be dealt at the same time. No side effects. Check out the website. www.glordavi.com/hcv

0 ( +0 / -0 )

Login to leave a comment

Facebook users

Use your Facebook account to login or register with JapanToday. By doing so, you will also receive an email inviting you to receive our news alerts.

Facebook Connect

Login with your JapanToday account

User registration

Articles, Offers & Useful Resources

A mix of what's trending on our other sites